10-Q: Waystar Holding Corp. Reports Q2 2024 Results, Revenue Up 19.7% Year-Over-Year

Waystar Holding Corp. announced its Q2 2024 financial results, showing a 19.7% increase in revenue compared to the same period last year, driven by growth in both subscription and volume-based revenue.

Summary

• Waystar Holding Corp. reported a net loss of $27.7 million for the three months ended June 30, 2024, compared to a net loss of $10.8 million for the same period in 2023.
• Revenue for the quarter reached $234.5 million, a 19.7% increase from $196.0 million in the prior year.
• The company's subscription revenue grew by 13.1% to $112.3 million, while volume-based revenue increased by 26.2% to $120.9 million.
• Operating expenses totaled $226.3 million, up from $158.8 million in the prior year, primarily due to increased stock-based compensation and higher transaction volumes.
• Adjusted EBITDA for the quarter was $93.9 million, compared to $83.8 million in the same period last year.
• For the six months ended June 30, 2024, Waystar reported a net loss of $43.6 million, compared to a net loss of $21.4 million for the same period in 2023.
• Revenue for the first six months of 2024 was $459.3 million, an 18.7% increase from $387.1 million in the prior year.
• The company's Net Revenue Retention Rate was 107.5% for the twelve months ended June 30, 2024.
• Waystar had 1,117 clients generating over $100,000 in revenue for the twelve months ended June 30, 2024.

Sentiment

Score: 6

Explanation: The document presents a mixed picture. While revenue growth is strong and the IPO was successful, the increased net loss and operating expenses are concerning. The company is navigating the transition to being a public company, which is reflected in the financial results. The sentiment is cautiously optimistic.

Positives

• Revenue growth of 19.7% in Q2 2024 demonstrates strong market demand for Waystar's solutions.
• The increase in both subscription and volume-based revenue indicates a healthy mix of recurring and transaction-based income.
• The Net Revenue Retention Rate of 107.5% shows strong client loyalty and expansion.
• The successful completion of the IPO and subsequent debt repayment strengthens the company's financial position.
• The company has a large client base with 1,117 clients generating over $100,000 in revenue.

Negatives

• The net loss increased significantly to $27.7 million in Q2 2024, compared to $10.8 million in Q2 2023.
• Operating expenses increased substantially, driven by stock-based compensation and higher transaction volumes.
• General and administrative expenses saw a large increase due to stock-based compensation and third-party fees related to debt repricing.
• The company experienced a loss on extinguishment of debt of $9.8 million in connection with the June 2024 First Lien paydown.

Risks

• The company operates in a highly competitive industry, which could impact its ability to retain clients and attract new ones.
• The company's growth depends on its ability to successfully execute its business strategies and integrate acquired businesses.
• The healthcare industry is heavily regulated, and changes in regulations could negatively impact the company's revenue.
• The company is dependent on its senior management team and key employees, and the loss of such personnel could harm the business.
• Cybersecurity incidents and data breaches could negatively impact the company's reputation and financial results.
• The company's ability to achieve or maintain profitability is uncertain given its history of net losses.

Future Outlook

The company expects to continue to grow its client base and expand its relationships with existing clients. They also anticipate lower interest expenses due to debt repayments, partially offset by losses on extinguishment of debt. The company also expects to incur stock-based compensation expenses related to equity awards granted in connection with the IPO and incremental public company expenses.

Industry Context

The company's performance is influenced by trends in the healthcare industry, including consolidation, regulatory changes, and the increasing adoption of technology solutions for revenue cycle management. The cybersecurity incident at a competitor also had a positive impact on Waystar's revenue in the short term.

Comparison to Industry Standards

• Waystar's revenue growth of 19.7% in Q2 2024 is strong compared to the overall healthcare technology sector, which is experiencing moderate growth.
• The company's Net Revenue Retention Rate of 107.5% is a positive indicator of client satisfaction and is above the industry average for SaaS companies.
• The increase in operating expenses, particularly in general and administrative, is higher than some peers, likely due to the costs associated with becoming a public company and the stock-based compensation related to the IPO.
• The company's adjusted EBITDA margin of 40.6% for the six months ended June 30, 2024 is competitive with other established healthcare technology companies, but the net loss is a concern.

Related Party Transactions

• The company had $33.2 million of outstanding debt with Bain Affiliated Funds and CPPIB Credit Investments III Inc., affiliates of Bain Capital LP and Canada Pension Plan Investment Board.
• Interest expense associated with and paid to Affiliated Debtholders was $1.3 million for the three months ended June 30, 2024.
• Canada Pension Plan Investment Board has an ownership interest in the company and a significant interest in the landlord that leases office space to the company in Houston, Texas.
• Bain Capital LP has an ownership interest in the company and a significant interest in some clients for whom the company provides software solutions and a vendor that provides software solutions to the company.

Stakeholder Impact

• Shareholders will benefit from the company's revenue growth and the successful IPO, but will be concerned about the increased net loss.
• Employees will benefit from the stock-based compensation and the company's growth prospects.
• Clients will benefit from the company's continued investment in its platform and solutions.
• Creditors will benefit from the company's debt repayments and improved financial position.

Next Steps

• The company will continue to focus on growing its client base and expanding its relationships with existing clients.
• Waystar will continue to invest in its platform and develop new solutions to meet the evolving needs of the healthcare industry.
• The company will manage its debt and interest expenses following the recent debt repayments.
• Waystar will manage the increased costs associated with being a public company.

Key Dates

Keywords

healthcare payments, revenue cycle management, SaaS, cloud technology, AI, EBITDA, IPO, debt repayment, Net Revenue Retention Rate, stock-based compensation